3D 生物列印人体组织市场报告：2030 年趋势、预测与竞争分析

3D 生物列印人体组织趋势与预测

到 2030 年，全球 3D 生物列印人体组织市场预计将达到 34 亿美元，2024 年至 2030 年复合年增长率为 7.8%。该市场的主要驱动力是免疫细胞疗法的日益增长、技术进步以及对定制 3D 列印、组织工程和器官替代的需求不断增长。全球3D生物列印人体组织市场的未来可能包括组织工程、整容手术、药物测试和开拓以及食品测试市场的机会。

• Lucintel 预测，由于临床试验应用的采用率增加，药物测试和开发领域预计将在预测期内实现最高成长。
• 由于政府研发支出增加，北美在预测期内仍是最大的地区。

3D生物列印人体组织市场的新兴趋势

3D 生物列印人体组织市场的新兴趋势反映了技术、应用和材料科学的进步。这些趋势正在塑造组织工程的未来，并为研究、医学和生物技术提供新的可能性。

• 强化生物材料：具有优异生物相容性和功能性的新型生物材料的开发正在加速。这些材料提高了生物列印组织的结构完整性和性能，使它们更适合再生医学和研究中的复杂应用。
• 血管新生技术：血管新生技术的创新对于创造更多功能的生物列印组织至关重要。将血管网络纳入生物列印结构的技术进步将促进组织存活和整合，使我们更接近功能齐全的器官替代品。
• 与人工智慧和机器学习的整合：人工智慧和机器学习在生物列印过程中的整合正在提高准确性和效率。这些技术可以帮助优化设计参数、预测组织行为并改善整体生物列印结果。
• 个人化医疗的应用：生物列印组织在个人化医疗中的应用引起了人们的注意。正在开发针对个别患者需求的自订生物列印组织，用于药物测试和治疗应用，从而提供更个人化的治疗选择。
• 再生医学的进步：再生医学的进步正在推动对生物列印组织的需求。创建功能性组织结构来修復或替换受损组织和器官的能力正在扩大 3D 生物列印的潜在应用。

增强型生物材料、血管生成技术、人工智慧整合、个人化医疗应用以及再生医学的进步等新兴趋势正在再形成3D 生物列印人体组织市场。这些趋势正在推动创新并扩大生物列印组织在研究和临床应用中的潜力。

3D生物列印人体组织市场的最新趋势

3D 生物列印人体组织市场的最新趋势突显了技术进步、材料改进和应用扩展。这些进展预计将改善生物列印组织的功能，并在研究和医学中得到应用。

• 先进的生物列印技术：新的生物列印技术正在提高生物列印组织的解析度和复杂性。这些进步使得能够创建更详细和功能性的组织模型，以提高效用。
• 生物材料配方的改进：生物材料配方的最新改进提高了生物列印组织的活力和功能。水凝胶和生物墨水等材料的创新提高了印刷结构的结构完整性和生物性能。
• 功能性组织结构：功能性组织结构创建的进步正在推动这一领域的发展。研究和开发正在开发具有复杂结构和功能的生物列印组织，例如具有整合血管网络的器官和组织，以获得更真实和有用的模型。
• 监管进展：最近的监管趋势正在推动生物列印组织的商业化。更新的指南和框架正在简化生物列印产品的核准流程，并促进从研究到临床应用的过渡。
• 合作研究计画：学术界、工业界和医疗保健组织之间加强合作正在推动 3D 生物列印领域的创新。这些伙伴关係正在加速生物列印组织的开发和应用，提高研究能力并扩大市场潜力。

3D 生物列印人体组织市场的主要发展包括生物列印技术的进步、生物材料配方的改进、功能组织结构的创建、监管进步和合作研究倡议。这些发展正在增强生物列印组织的功能和应用。

3D 生物列印人体组织市场的策略性成长机会

3D 生物列印人体组织市场在各种应用中提供了策略性成长机会。这些机会是由技术进步、对个人化医疗的需求不断增长以及研究和治疗应用的扩展所推动的。

• 药物发现和测试：生物列印组织越来越多地用于药物发现和测试。该应用程式提供了创建更准确的人体组织模型以评估药物功效和安全性的机会，从而减少对动物测试的依赖。
• 再生医学：生物列印组织在再生医学的潜力巨大。有机会发展组织结构来修復或替换受损的器官和组织，描述针对各种疾病状态的新治疗方法。
• 个人化医疗：生物列印组织在个人化医疗中的使用正在扩大。自订的生物列印组织正在开发中，以匹配个别患者的遗传特征和医疗需求，从而提供更有效和个人化的治疗选择。
• 研究与开发：生物列印纸巾的研发市场正在扩大。生物列印模型为研究疾病机制、组织发育和细胞相互作用提供了宝贵的工具，促进了生物医学研究的创新。
• 临床应用：生物列印技术的进步正在扩大临床应用的机会。随着技术的成熟，生物列印组织被考虑直接用于临床治疗损伤和退化性疾病。

3D生物列印人体组织市场的策略性成长机会包括在药物发现、再生医学、个人化医疗、研究与开发以及临床应用方面的应用。这些机会反映出生物列印组织在改变医疗保健和研究各个方面的潜力不断扩大。

3D生物列印人体组织市场驱动因素与挑战

3D生物列印人体组织市场受到各种市场驱动因素和挑战的影响，包括技术进步、经济因素和监管问题。了解这些因素对于驾驭市场和实现成长至关重要。

推动 3D 生物列印人体组织市场的因素包括：

1.技术进步：生物列印技术的创新增强了生物列印组织的功能和应用。印刷技术、材料和设计软体的进步正在推动市场成长并扩大可能性。

2. 增加研究经费：增加研发投资正在支持生物列印组织的进步。来自政府、私营部门和学术界的资金加速了创新并促进了市场扩张。

3. 对个人化医疗的需求：对个人化医疗日益增长的需求正在推动对自订生物列印组织的需求。个人化治疗和药物试验需要紧密模仿个别患者特征的组织。

4.再生医学的潜力：生物列印组织在再生医学的潜力是兴趣和投资的驱动力。生物列印描述了修復或替换受损组织和器官的新解决方案。

5. 监管支持：不断发展的法律规范正在促进生物列印组织的商业化。更新的指南和标准将简化核准流程并支援市场成长。

3D生物列印人体组织市场面临的挑战如下：

1.高成本：生物列印技术和材料的高成本是其广泛使用的障碍。解决成本问题对于使生物列印纸巾更容易获得和负担得起至关重要。

2.技术限制：目前生物列印的技术限制，例如实现复杂的组织结构和整合血管网络，带来了挑战。克服这些限制对于该细分市场的发展至关重要。

3. 监管障碍：了解生物列印组织的监管要求很复杂。确保满足安全性和有效性标准对于市场进入和接受是必要的。

3D生物列印人体组织市场是由技术进步、研究经费增加、个人化医疗需求、再生医学潜力和监管支援所推动的。挑战包括高成本、技术限制、监管障碍、可扩展性问题和道德问题。解决这些因素是市场成长和成功的关键。

3D 生物列印人体组织的特定片段预测

这项研究包括按应用和地区对全球 3D 生物列印人体组织进行的预测。

3D生物列印人体组织市场国家展望

市场上的主要企业正在透过扩大业务和建立策略伙伴关係关係来巩固自己的地位。下图突显了美国、中国、印度、日本和德国等关键地区 3D 生物列印人体组织製造商的最新趋势。

• 美国：美国在开发用于药物测试和再生医学的复杂组织结构方面取得了巨大进展。公司专注于增强组织血管化和功能，在更准确地模仿人体生理学的生物列印器官和组织方面取得突破。
• 中国：中国在扩展 3D 生物列印技术方面取得了长足进步，特别是在创建用于医学研究和测试的组织模型方面。在政府的支持和资助下，生物列印能力正在加速进步，旨在使中国成为生物列印组织开发的领导者。
• 德国：德国在3D生物列印领域正在取得进展，重点是整合先进的生物材料和改进组织工程技术。德国研究机构正在努力提高生物列印组织的精确度和复杂性，以支持药物发现和再生疗法。
• 印度：印度的重点是开发具有成本效益的生物列印解决方案和扩大研究能力。印度研究机构和新兴企业正在创建用于研究和医疗用途的生物列印纸巾，重点是更广泛使用的经济性和可及性。
• 日本：日本在先进生物列印技术和材料的开发方面处于领先地位。日本研究人员正专注于再生医学的生物列印功能组织结构，并探索合作研究将这些技术整合到临床应用中。

常问问题

Q1.市场规模有多大？

答：到 2030 年，全球 3D 生物列印人体组织市场预计将达到 34 亿美元。

Q2.市场成长预测如何？

答：2024年至2030年，全球3D生物列印人体组织市场预计将以7.8%的复合年增长率成长。

Q3.影响市场成长的关键驱动因素有哪些？

答：该市场的主要驱动力是免疫细胞疗法的日益普及、技术进步以及对定制 3D 列印、组织工程和器官替代的需求不断增长。

Q4.市场的主要细分市场有哪些？

答：3D生物列印人体组织市场前景广阔，在组织工程、整容手术、药物测试和开拓以及食品测试市场都有机会。

Q5.市场上主要企业有哪些？

答：3D生物列印人体组织的主要企业有：

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

Q6.未来最大的细分市场是什么？

答：Lucintel 预计，由于临床试验应用的采用率不断提高，药物测试和开发领域将在预测期内达到最高成长。

Q7. 预计未来五年哪个地区将成为最大的市场？

答：由于政府研发支出增加，北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

答：是的，Lucintel 列出了 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球 3D 生物列印人体组织市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球3D生物列印人体组织市场趋势（2018-2023）与预测（2024-2030）
• 全球 3D 生物列印人体组织市场（按应用）
  • 组织工程
  • 整容手术
  • 药物测试和开发
  • 食品检测
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 全球 3D 生物列印人体组织市场（按地区）
• 北美3D生物列印人体组织市场
• 欧洲3D生物列印人体组织市场
• 亚太地区 3D 生物列印人体组织市场
• 其他地区3D生物列印人体组织市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球 3D 生物列印人体组织市场成长机会（按应用）
  • 全球 3D 生物列印人体组织市场成长机会（按地区）
• 全球3D生物列印人体组织市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球3D生物列印人体组织市场的产能
  • 全球3D生物列印人体组织市场的併购与合资企业
  • 认证和许可

第七章主要企业概况

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

3D Bioprinted Human Tissue Trends and Forecast

The future of the global 3D bioprinted human tissue market looks promising with opportunities in the tissue engineering, cosmetic surgery, drug testing and development, and food testing markets. The global 3D bioprinted human tissue market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing inclination towards immune cellular therapies, progress in technology, and rising demand for customized 3D printing, tissue engineering and organ replacement.

• Lucintel forecasts that drug testing and development segment is expected to witness the highest growth over the forecast period due to its increasing adoption in the clinical trial applications.
• North America will remain the largest region over the forecast period due to rising government R&D spending.

Emerging Trends in the 3D Bioprinted Human Tissue Market

Emerging trends in the 3D bioprinted human tissue market reflect advancements in technology, applications, and material science. These trends are shaping the future of tissue engineering, offering new possibilities for research, medicine, and biotechnology.

• Enhanced Biomaterials: Development of new biomaterials with better biocompatibility and functionality is accelerating. These materials improve the structural integrity and performance of bioprinted tissues, making them more suitable for complex applications in regenerative medicine and research.
• Vascularization Techniques: Innovations in vascularization techniques are crucial for creating more functional bioprinted tissues. Advances in incorporating vascular networks within bioprinted constructs enhance tissue survival and integration, bringing us closer to fully functional organ replacements.
• Integration with AI and Machine Learning: The integration of AI and machine learning in bioprinting processes is improving precision and efficiency. These technologies help optimize design parameters, predict tissue behavior, and enhance overall bioprinting outcomes.
• Personalized Medicine Applications: There is a growing focus on using bioprinted tissues for personalized medicine. Custom bioprinted tissues tailored to individual patients' needs are being developed for drug testing and therapeutic applications, offering more personalized treatment options.
• Regenerative Medicine Advancements: Advances in regenerative medicine are driving the demand for bioprinted tissues. The ability to create functional tissue constructs for repairing or replacing damaged tissues and organs is expanding the potential applications of 3D bioprinting.

Emerging trends such as enhanced biomaterials, vascularization techniques, AI integration, personalized medicine applications, and regenerative medicine advancements are reshaping the 3D bioprinted human tissue market. These trends are driving innovation and expanding the possibilities for bioprinted tissues in research and clinical applications.

Recent Developments in the 3D Bioprinted Human Tissue Market

Recent developments in the 3D bioprinted human tissue market highlight technological advancements, improved materials, and expanded applications. These developments are advancing the capabilities of bioprinted tissues and their potential uses in research and medicine.

• Advanced Bioprinting Technologies: New bioprinting technologies are enhancing the resolution and complexity of bioprinted tissues. These advancements allow for the creation of more detailed and functional tissue models, improving their utility for research and therapeutic applications.
• Improved Biomaterial Formulations: Recent improvements in biomaterial formulations are increasing the viability and functionality of bioprinted tissues. Innovations in materials such as hydrogels and bio-inks enhance the structural integrity and biological performance of the printed constructs.
• Functional Tissue Constructs: Progress in creating functional tissue constructs is advancing the field. Researchers are developing bioprinted tissues with complex structures and functionalities, such as organs and tissues with integrated vascular networks, for more realistic and useful models.
• Regulatory Advances: Recent regulatory developments are supporting the commercialization of bioprinted tissues. Updated guidelines and frameworks are helping to streamline the approval processes for bioprinted products, facilitating their transition from research to clinical applications.
• Collaborative Research Initiatives: Increased collaboration between academia, industry, and healthcare institutions is driving innovation in 3D bioprinting. These partnerships are accelerating the development and application of bioprinted tissues, enhancing research capabilities and expanding market potential.

Key developments in the 3D bioprinted human tissue market include advancements in bioprinting technologies, improved biomaterial formulations, creation of functional tissue constructs, regulatory advances, and collaborative research initiatives. These developments are enhancing the capabilities and applications of bioprinted tissues.

Strategic Growth Opportunities for 3D Bioprinted Human Tissue Market

The 3D bioprinted human tissue market offers strategic growth opportunities across various applications. These opportunities are driven by technological advancements, increasing demand for personalized medicine, and expanding research and therapeutic applications.

• Drug Discovery and Testing: Bioprinted tissues are increasingly used for drug discovery and testing. This application provides opportunities to create more accurate models of human tissues for evaluating drug efficacy and safety, reducing reliance on animal testing.
• Regenerative Medicine: The potential for bioprinted tissues in regenerative medicine is significant. Opportunities exist in developing tissue constructs for repairing or replacing damaged organs and tissues, offering new treatments for various medical conditions.
• Personalized Medicine: The use of bioprinted tissues for personalized medicine is growing. Custom bioprinted tissues tailored to individual patients' genetic profiles and medical needs are being developed, providing more effective and personalized treatment options.
• Research and Development: The market for bioprinted tissues in research and development is expanding. Bioprinted models offer valuable tools for studying disease mechanisms, tissue development, and cellular interactions, driving innovation in biomedical research.
• Clinical Applications: Increasing advancements in bioprinting technology are opening opportunities for clinical applications. As the technology matures, bioprinted tissues are being explored for direct clinical use in treating injuries and degenerative diseases.

Strategic growth opportunities in the 3D bioprinted human tissue market include applications in drug discovery, regenerative medicine, personalized medicine, research and development, and clinical applications. These opportunities reflect the expanding potential of bioprinted tissues to transform various aspects of healthcare and research.

3D Bioprinted Human Tissue Market Driver and Challenges

The 3D bioprinted human tissue market is shaped by various drivers and challenges, including technological advancements, economic factors, and regulatory issues. Understanding these factors is crucial for navigating the market and achieving growth.

The factors responsible for driving the 3d bioprinted human tissue market include:

1. Technological Advancements: Innovations in bioprinting technology enhance the capabilities and applications of bioprinted tissues. Advances in printing techniques, materials, and design software drive market growth and expand possibilities.

2. Increased Research Funding: Growing investment in research and development supports the advancement of bioprinted tissues. Funding from government, private, and academic sources accelerates innovation and drives market expansion.

3. Demand for Personalized Medicine: Rising demand for personalized medicine fuels the need for custom bioprinted tissues. Personalized treatments and drug testing require tissues that closely mimic individual patient characteristics.

4. Regenerative Medicine Potential: The potential for bioprinted tissues in regenerative medicine drives interest and investment. Bioprinting offers new solutions for repairing or replacing damaged tissues and organs.

5. Regulatory Support: Evolving regulatory frameworks are facilitating the commercialization of bioprinted tissues. Updated guidelines and standards help streamline the approval process and support market growth.

Challenges in the 3d bioprinted human tissue market are:

1. High Costs: The high costs of bioprinting technology and materials pose a barrier to widespread adoption. Addressing cost issues is essential for making bioprinted tissues more accessible and affordable.

2. Technical Limitations: Current technical limitations in bioprinting, such as achieving complex tissue structures and integrating vascular networks, present challenges. Overcoming these limitations is crucial for advancing the field.

3. Regulatory Hurdles: Navigating regulatory requirements for bioprinted tissues can be complex. Ensuring compliance with safety and efficacy standards is necessary for market entry and acceptance.

The 3D bioprinted human tissue market is driven by technological advancements, increased research funding, demand for personalized medicine, regenerative medicine potential, and regulatory support. Challenges include high costs, technical limitations, regulatory hurdles, scalability issues, and ethical concerns. Addressing these factors is key to market growth and success.

List of 3D Bioprinted Human Tissue Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies 3D bioprinted human tissue companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 3D bioprinted human tissue companies profiled in this report include-

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

3D Bioprinted Human Tissue by Segment

The study includes a forecast for the global 3D bioprinted human tissue by application and region.

3D Bioprinted Human Tissue Market by Application [Analysis by Value from 2018 to 2030]:

• Tissue Engineering
• Cosmetic Surgery
• Drug Testing and Development
• Food Testing
• Others

3D Bioprinted Human Tissue Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the 3D Bioprinted Human Tissue Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below image highlights recent developments by major 3D bioprinted human tissue producers in key regions: the USA, China, India, Japan, and Germany

• United States: In the U.S., significant progress has been made with the development of complex tissue structures for drug testing and regenerative medicine. Companies are focusing on enhancing tissue vascularization and functionality, with breakthroughs in bioprinting organs and tissues that mimic human physiology more accurately.
• China: China is making strides in scaling up 3D bioprinting technologies, particularly in creating tissue models for medical research and testing. The government's support and funding have accelerated advancements in bioprinting capabilities, aiming to establish China as a leader in bioprinted tissue development.
• Germany: Germany has been advancing in the field of 3D bioprinting with an emphasis on integrating advanced biomaterials and improving tissue engineering techniques. German research institutions are working on enhancing the precision and complexity of bioprinted tissues to support drug discovery and regenerative therapies.
• India: In India, the focus is on developing cost-effective bioprinting solutions and scaling up research capabilities. Indian institutions and startups are making progress in creating bioprinted tissues for research and medical applications, with an emphasis on affordability and accessibility for broader use.
• Japan: Japan is leading in the development of advanced bioprinting technologies and materials. The Japanese researchers are focusing on the bioprinting of functional tissue constructs for regenerative medicine and exploring collaborations to integrate these technologies into clinical applications.

Features of the Global 3D Bioprinted Human Tissue Market

Market Size Estimates: 3D bioprinted human tissue market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: 3D bioprinted human tissue market size by application and region in terms of value ($B).

Regional Analysis: 3D bioprinted human tissue market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications and regions for the 3D bioprinted human tissue market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the 3D bioprinted human tissue market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the 3D bioprinted human tissue market size?

Answer: The global 3D bioprinted human tissue market is expected to reach an estimated $3.4 billion by 2030.

Q2. What is the growth forecast for 3D bioprinted human tissue market?

Answer: The global 3D bioprinted human tissue market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the 3D bioprinted human tissue market?

Answer: The major drivers for this market are increasing inclination towards immune cellular therapies, progress in technology, and rising demand for customized 3D printing, tissue engineering and organ replacement.

Q4. What are the major segments for 3D bioprinted human tissue market?

Answer: The future of the 3D bioprinted human tissue market looks promising with opportunities in the tissue engineering, cosmetic surgery, drug testing and development, and food testing markets.

Q5. Who are the key 3D bioprinted human tissue market companies?

Answer: Some of the key 3D bioprinted human tissue companies are as follows:

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

Q6. Which 3D bioprinted human tissue market segment will be the largest in future?

Answer: Lucintel forecasts that drug testing and development segment is expected to witness the highest growth over the forecast period due to its increasing adoption in the clinical trial applications.

Q7. In 3D bioprinted human tissue market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising government R&D spending.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the 3D bioprinted human tissue market by application (tissue engineering, cosmetic surgery, drug testing and development, food testing, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global 3D Bioprinted Human Tissue Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global 3D Bioprinted Human Tissue Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global 3D Bioprinted Human Tissue Market by Application
  • 3.3.1: Tissue Engineering
  • 3.3.2: Cosmetic Surgery
  • 3.3.3: Drug Testing and Development
  • 3.3.4: Food Testing
  • 3.3.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global 3D Bioprinted Human Tissue Market by Region
• 4.2: North American 3D Bioprinted Human Tissue Market
  • 4.2.1: North American 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
• 4.3: European 3D Bioprinted Human Tissue Market
  • 4.3.1: European 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
• 4.4: APAC 3D Bioprinted Human Tissue Market
  • 4.4.1: APAC 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
• 4.5: ROW 3D Bioprinted Human Tissue Market
  • 4.5.1: ROW 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Application
  • 6.1.2: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Region
• 6.2: Emerging Trends in the Global 3D Bioprinted Human Tissue Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global 3D Bioprinted Human Tissue Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global 3D Bioprinted Human Tissue Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Organovo
• 7.2: Stratasys
• 7.3: 3D Systems
• 7.4: SOLS Systems
• 7.5: Youbionic